Covidien Company Description
No longer one of the Tyco family, Covidien is striking out on its own in the medical supplies marketplace. Its former parent spun off the unit (previously known as Tyco Healthcare) in 2007, as part of the conglomerate's much-anticipated break-up. With about $10 billion in annual sales and a product offering that includes thousands of different brands (including Mallinckrodt and Kendall), Tyco's offspring is no mewling infant. The firm supplies health care providers around the world with everything from generic pharmaceuticals and disposable medical products to diagnostic imaging contrast agents and surgical devices. Covidien has operations in nearly 60 countries.
View the Comprehensive Company Description for Covidien
The Company Description provides a historical perspective of Covidien's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Covidien's evolution in the marketplace.
